Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization
Authors:
- Wen-Quan WangWWWen-Quan Wang
- Liang LiuLLLiang Liu
- Hui-Chuan SunHSHui-Chuan Sun
- Yan-Ling FuYFYan-Ling Fu
- Hua-Xiang XuHXHua-Xiang Xu
- Zong-Tao ChaiZCZong-Tao Chai
- Qiang-Bo ZhangQZQiang-Bo Zhang
- Ling-Qun KongLKLing-Qun Kong
- Xiao-Dong ZhuXZXiao-Dong Zhu
- Lu LuLLLu Lu
- Zheng-Gang RenZRZheng-Gang Ren
- Zhao-You TangZTZhao-You Tang
Open Access
- 8 November 2012
- journal article
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 5 (1) , 69
Abstract
Background: Promotion of endothelial normalization restores tumor oxygenation and obstructs tumor cells invasion, intravasation, and metastasis. We therefore investigated whether a vasoactive drug, tanshinone IIA, could inhibit metastasis by inducing vascular normalization after palliative resection (PR) of hepatocellular carcinoma (HCC). Methods: A liver orthotopic double-tumor xenograft model in nude mouse was established by implantation of HCCLM3 (high metastatic potential) and HepG2 tumor cells. After removal of one tumor by PR, the effects of tanshinone IIA administration on metastasis, tumor vascularization, and survival were evaluated. Tube formation was examined in mouse tumor-derived endothelial cells (TECs) treated with tanshinone IIA. Results: PR significantly accelerated residual hepatoma metastases. Tanshinone IIA did not inhibit growth of single-xenotransplanted tumors, but it did reduce the occurrence of metastases. Moreover, it inhibited PR-enhanced metastases and, more importantly, prolonged host survival. Tanshinone IIA alleviated residual tumor hypoxia and suppressed epithelial-mesenchymal transition (EMT) in vivo; however, it did not downregulate hypoxia-inducible factor 1α (HIF-1α) or reverse EMT of tumor cells under hypoxic conditions in vitro. Tanshinone IIA directly strengthened tube formation of TECs, associated with vascular endothelial cell growth factor receptor 1/platelet derived growth factor receptor (VEGFR1/PDGFR) upregulation. Although the microvessel density (MVD) of residual tumor tissue increased after PR, the microvessel integrity (MVI) was still low. While tanshinone IIA did not inhibit MVD, it did dramatically increase MVI, leading to vascular normalization. Conclusions: Our results demonstrate that tanshinone IIA can inhibit the enhanced HCC metastasis associated with PR. Inhibition results from promoting VEGFR1/PDGFR-related vascular normalization. This application demonstrates the potential clinical benefit of preventing postsurgical recurrence.Keywords
This publication has 31 references indexed in Scilit:
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Operative injury accelerates tumor growth by inducing mobilization and recruitment of bone marrow–derived stem cellsSurgery, 2011
- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGFCancer Cell, 2011
- Surgical Injury Enhances the Expression of Genes That Mediate Breast Cancer Metastasis to the LungAnnals of Surgery, 2010
- Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse modelHepatology, 2010
- Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2010
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor AngiogenesisCancer Cell, 2009
- Hepatic Resection but Not Radiofrequency Ablation Results in Tumor Growth and Increased Growth Factor ExpressionAnnals of Surgery, 2007
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- High-lose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potentialHepatology, 2000